UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): September 4, 2019
|
SECOND SIGHT MEDICAL PRODUCTS, INC. |
|
|
(Exact Name of Registrant as Specified in Its Charter) |
|
|
California |
|
|
(State or Other Jurisdiction of Incorporation) |
|
|
|
|
|
001-36747 |
02-0692322 |
|
(Commission File Number) |
(IRS Employer Identification No.) |
|
12744 San Fernando Road, Suite 400 |
|
|
|
|
|
(Address of Principal Executive Offices) |
|
|
|
|
|
(818) 833-5000 |
|
|
(Registrant's Telephone Number, Including Area Code) |
|
|
(Former Name or Former Address, if Changed Since Last Report) |
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
Common Stock |
|
EYES |
|
Nasdaq |
|
|
Warrants |
|
EYESW |
|
Nasdaq |
|
|
|
-1- |
|
|
|
|
|
ITEM 7.01. REGULATION FD DISCLOSURE
Second Sight Medical Products, Inc. (“Second Sight” or the “Company”), will make presentations at investment conferences as described in Item 8.01 below (“Conferences”). A copy of a slide presentation that Will McGuire, President and Chief Executive Officer and John Blake, Chief Financial Officer, intend to use (the “Presentation Materials”) during the Conferences is attached to this Current Report on Form 8-K as Exhibit 99.1, and is incorporated by reference herein. The Presentation Materials speak as of the date of this Current Report on Form 8-K. While Second Sight may elect to update the Presentation Materials in the future or reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K, Second Sight specifically disclaims any obligation to do so. The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by reference in such a filing.
ITEM 8.01 Other Events
Will McGuire, President and Chief Executive Officer and John Blake, Chief Financial Officer, will make presentations as follows:
Conference:2019 Wells Fargo Healthcare Conference
Date:Wednesday, September 4, 2019
Time:3:00 P.M. Eastern Daylight Time
Location:Westin Copley Place, Boston, MA
Webcast:https://cc.talkpoint.com/well001/090419a_js/?entity=79_DOKDK3H
Presenter: Will McGuire, Chief Executive Officer
The Wells Fargo presentation will be webcast live at the aforementioned time and will be archived for 30 days thereafter, via the Company’s website at www.secondsight.com, under the Investors Section.
Conference:4th Annual Dougherty & Company Institutional Investor Conference
Date:Thursday, September 5, 2019
Location:Millennium Hotel, Minneapolis, MN
Event format:1x1 meetings
Presenter:John Blake, Chief Financial Officer
Conference:H.C. Wainwright 21st Annual Global Investment Conference
Date:Monday, September 9, 2019
Time:2:10 P.M. Eastern Daylight Time
Location:Lotte New York Palace Hotel, New York, NY
Presenter: Will McGuire, Chief Executive Officer
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
Exhibit No. Description
99.1 Presentation Materials dated September 4, 2019.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SECOND SIGHT MEDICAL PRODUCTS, INC.
/s/ John T. Blake
By: John T. Blake
|
|
-2- |
|
|
|
|
|